Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

A meta-analysis tied Lactobacillus acidophilus L-92 to a 41% lower risk of gut side effects during cancer treatment — but didn’t find any improvement in how well patients actually responded to the cancer therapy itself.
- 2026-02
- Meta-Analysis
- n = 37
- The Journal of nutrition
This is the first solid evidence linking this specific probiotic to fewer bouts of diarrhea, constipation, nausea, and vomiting in people undergoing cancer treatment, but because it's an early meta-analysis with a small sample (37 participants, and the individual studies disagree a lot), the finding needs replication before you'd act on it.
New evidenceLactobacillus acidophilus L-92 for Reduced Gastrointestinal Adverse Events
Crocin from gardenia slashed TNF-α by nearly 2 standard deviations in a meta-analysis — but the same review found it did nothing for two other inflammation markers.
- 2024-12-04
- Meta-Analysis
- Phytotherapy research : PTR
This is the first meta-analysis on crocin and inflammation, so the finding is promising but still preliminary — the large effect on TNF-α needs replication before you can count on it.
SurprisingGardenia for Reduced Tumor Necrosis Factor Alpha
In a 40-patient pilot trial, intravenous vitamin C (1.5 g every 6 hours for 3 days) slashed acute kidney injury rates from 70% to 25% in sepsis patients — but the effect on mortality was zero.
- 2026-02-04
- RCT
- n = 40
- International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition
This is a striking signal from a very small, early-stage study in a specific clinical population (sepsis patients in the ICU), so while the kidney protection looks real, the finding needs replication in much larger trials before it applies broadly.
Big effectVitamin C for Reduced Acute Kidney Injury
International consensus on MELAS finds L-arginine and other supplements still unproven for stroke-like episodes
- 2026-04
- Systematic Review
- European journal of neurology
As one of the first indexed systematic reviews on this specific pairing, this expert consensus challenges the belief that L-arginine helps — but because it’s an opinion-based statement, not a trial, it doesn’t settle the question either.
Myth-busterL-Arginine for Reduced Stroke-Like Episode Severity
Zinc adherence for childhood diarrhea hit only 63% in a meta-analysis — though the data came from just 10 observational studies with no blinding.
- 2025
- Meta-Analysis
- n = 10
- Epidemiology and infection
This review suggests many caregivers don't complete the full zinc regimen, but because all studies were observational and small, we can't be sure how much poor adherence is driven by the supplement itself versus broader social and economic barriers.
Myth-busterZinc for Improved Zinc Supplementation Adherence
Turmeric slashed CRP in a five-day trial — but only in COVID-19 outpatients, and ginger worked just as well
- 2025-08-21
- RCT
- n = 144
- Scientific reports
This triple-blind RCT suggests turmeric can rapidly lower inflammation in people who are already sick with COVID-19, but the effect was identical to ginger, the study lasted only five days, and it's the first of its kind — so don't assume the same benefit for healthy people or longer-term use.
Big effectTurmeric for Reduced C-Reactive Protein Levels
Tongue brushing alone cut halitosis in an 80-person trial — but adding Streptococcus salivarius K12 kept breath fresher even after the intervention stopped.
- 2026-02-10
- RCT
- n = 80
- Journal of breath research
This small, double-blind trial suggests the probiotic may extend the benefit of tongue brushing beyond the active treatment period, but the novelty of this specific pairing means the finding needs replication before it becomes actionable advice.
SurprisingStreptococcus salivarius K12 for Reduced Halitosis
Chewable Lactobacillus rhamnosus GG reached the nose and slashed nasal IL-13 in allergy patients — but this single early trial didn't test whether it works for anyone without allergic rhinitis.
- 2025-10-07
- RCT
- Microbiology spectrum
This is the first solid evidence that a specific probiotic strain, delivered via a chewable tablet, can directly colonize the upper airways and locally reduce key inflammatory cytokines — but with only one study so far, the finding is a promising lead, not a settled fact.
New evidenceLactococcus lactis L1A-23 for Reduced Pro-Inflammatory Cytokines
Probiotic L. helveticus Rosell-52 failed to improve red blood cell measures in a 116-person trial of adults with depression — the same study hinted at a stabilizing effect on some hemoglobin markers, but the primary analysis found no significant benefit over placebo.
- 2025-01-05
- RCT
- n = 116
- Journal of clinical medicine
This null result challenges any expectation that this specific probiotic strain meaningfully boosts red blood cell health in people with depression, but since it's one of the first studies on this pairing, the picture is far from settled — more research is needed before drawing firm conclusions.
Myth-busterLactobacillus helveticus Rosell-52 for No Significant Changes in Blood Parameters
Lactobacillus casei failed to improve bladder cancer recurrence-free survival in a meta-analysis — no benefit over standard care.
- 2025-04
- Meta-Analysis
- Clinical genitourinary cancer
This is among the first systematic reviews on this specific pairing, so the null result doesn't settle the question — but it provides the strongest evidence yet that L. casei alone may not reduce recurrence.
Myth-busterLactobacillus casei for Improved Intravesical Recurrence-Free Survival
Chromium picolinate lowered HbA1c by 0.68% in 12 weeks — but only in a small trial of people with metabolic syndrome
- 2026-03-17
- RCT
- n = 48
- Biological trace element research
This is one of the first controlled trials to show chromium picolinate can improve long-term blood sugar control in metabolic syndrome, but the modest effect and small sample mean the finding needs replication before it's actionable.
TrendingChromium for Reduced Hemoglobin A1c
Halitosis reduction from a mouthwash made of clematis extract matched chlorhexidine in a 2-week trial — but this is the first study of its kind.
- 2026-06
- RCT
- n = 67
- Complementary therapies in medicine
This small, early-stage trial suggests clematis might work for bad breath, but the evidence is too thin to act on — treat it as a preliminary signal, not a recommendation.
SurprisingClematis for Reduced Halitosis
Vitamin D supplements improved leg function after stroke – but the meta-analysis leans on only 123 patients, all from unblinded trials.
- 2025-04-28
- Meta-Analysis
- n = 123
- Narra J
With just 123 participants and no blinding, this early evidence hints at a potential benefit for stroke rehabilitation, but the picture is far from settled – larger, rigorous trials are needed before drawing conclusions.
SurprisingVitamin D for Improved Functional Ambulation Classification
A meta-analysis linked Bifidobacterium animalis to a 21% lower risk of respiratory infections — but the finding rests on just three trials with 751 participants total.
- 2025-10
- Meta-Analysis
- n = 751
- EClinicalMedicine
This is one of the first systematic looks at this specific probiotic for respiratory infections, so while the effect is promising and statistically significant, the small number of trials means the real-world benefit could be smaller — or even absent — once larger studies are done.
Big effectBifidobacterium animalis for Reduced Upper Respiratory Infections
Early NAC administration significantly improved symptom resolution in mild traumatic brain injury — but the systematic review's overall evidence was fragmented and at high risk of bias.
- 2026-03-27
- Systematic Review
- International journal of molecular sciences
This is among the first indexed studies on NAC for mild TBI, so the finding is promising but far from settled — especially since the same review found no significant effect on cognitive stabilization and no effect on oxidative stress markers, narrowing the potential benefit.
New evidenceN-Acetyl Cysteine for Improved Symptom Resolution
30 days of cocoa flavanols shrank a key heart chamber by 12.6% in healthy older adults—but other markers of heart function didn't budge.
- 2025
- RCT
- Food & function
This is the first rigorous trial to link cocoa flavanols to a measurable reversal of early diastolic dysfunction, but with only one study so far, the effect needs replication before it becomes actionable.
New evidenceCocoa for Reduced Left Atrial Maximal Volume
Fermented camel milk, grape juice, and pomegranate juice all failed to improve pediatric metabolic syndrome in a systematic review.
- 2025-05-28
- Systematic Review
- BMC pediatrics
This null result from a systematic review of clinical studies suggests that these natural products are unlikely to help children with metabolic syndrome — but because this is among the first indexed reviews on this specific pairing, the picture isn't settled, and the finding applies only to a clinical pediatric population.
Myth-busterVitamin D for Improved Metabolic Health
Black cumin supplements cut TNF-alpha by an effect size of -1.27 in a meta-analysis — a large drop, but the dose that produced it wasn't reported.
- 2025-01
- Meta-Analysis
- Prostaglandins & other lipid mediators
This unusually large effect comes from a synthesis of three studies that all found benefit, but the missing dose details and the wide confidence interval (from -2.29 to -0.25) mean the result is promising rather than actionable.
Big effectBlack Cumin for Reduced Tumor Necrosis Factor Alpha
A 36% larger improvement in blood vessel dilation with 3 g/day L-citrulline — but only in people with high-normal blood pressure at baseline.
- 2026-06
- RCT
- n = 66
- Nutrition research (New York, N.Y.)
This moderate-sized, rigorous trial adds to a consistent body of evidence (5 out of 5 studies beneficial) that L-citrulline can improve vascular function, but the effect appears to depend on starting blood pressure — meaning healthy people with low-normal BP might not see the same benefit.
Big effectL-Citrulline for Improved Flow-Mediated Dilation
In a 136-person RCT, Lactobacillus reuteri supplements did not change human milk oligosaccharide levels in colostrum or mature milk.
- 2025-08
- RCT
- n = 136
- Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
This null result challenges the popular idea that probiotic strains like L. reuteri can directly shape the complex sugar profile of breast milk — but because this is among the first controlled trials on this specific pairing, the picture is far from settled.
Myth-busterLactobacillus reuteri for Increased Human Milk Oligosaccharide Level
Heat-killed Lactobacillus sakei improved cheek moisture in a 60-woman trial — but the benefit was clearest in women in their 40s, and other skin measures showed no significant change.
- 2025-12
- RCT
- n = 60
- Journal of cosmetic dermatology
This is one of the first controlled studies on this specific postbiotic for skin, so the findings are preliminary and need replication before drawing firm conclusions.
TrendingLactobacillus sakei proBio65 for Improved Skin Moisture Retention
A meta-analysis of 21 trials linked Lactobacillus casei HA-108 to a 0.72 mmol/L drop in fasting glucose — but the same analysis found zero effect on androgen levels, lipids, or reproductive hormones.
- 2026-03-04
- Systematic Review
- n = 1,144
- BMC endocrine disorders
This is the first solid evidence that this specific probiotic strain may improve blood sugar control, but the benefit looks narrow (no help for hormones or cholesterol) and comes from a single meta-analysis — early data, not a settled fact.
New evidenceLactobacillus casei HA-108 for Improved Glycemia
A three-month trial found 16g of flaxseed daily slashed HbA1c and other metabolic markers in type 2 diabetes — but the results come from a single, early-stage study in a specific population, so handle with caution.
- 2025-02-17
- RCT
- Nutrients
This is one of the first controlled trials to show a clear, large effect of flaxseed on multiple diabetes-related blood markers, but because it's so new and limited to Mexican adults with type 2 diabetes, it's a promising clue rather than a settled fact.
Big effectflaxseed for Reduced Glycated Hemoglobin
In kids with acute gastroenteritis, a high-dose probiotic cut persistent watery diarrhea from 58.6% to 19.4% by day 5 — but the trial was set in a hospital emergency department, so the results may not apply to milder cases managed at home.
- 2025-03-03
- RCT
- Journal of pediatric gastroenterology and nutrition
This is a striking effect in a well-controlled clinical setting, and it adds to a body of 11 randomized trials where most (8) also found benefit, though effect sizes have varied widely — so while the probiotic looks promising for severe pediatric diarrhea, the strength of evidence is not yet uniform across all contexts.
Big effectLactobacillus reuteri DSM 17938 for Reduced Diarrhea Rate
Saccharomyces boulardii cut diarrhea risk by 64% in a meta-analysis — but only for people on H. pylori treatment
- 2025-02-12
- Meta-Analysis
- Frontiers in cellular and infection microbiology
With nine studies all pointing in the same direction, the evidence for Saccharomyces boulardii reducing diarrhea during H. pylori therapy is strong — but this doesn't mean it works for other types of diarrhea.
Big effectsaccharomyces boulardii for Reduced Diarrhea
Bifidobacterium slashed a marker of oxidative stress by a large margin in a meta-analysis — but the effect was strongest in people under 70 with existing cognitive decline.
- 2025-09
- Meta-Analysis
- n = 1,195
- Ageing research reviews
This is among the first meta-analyses to link Bifidobacterium to a sharp drop in malondialdehyde (a marker of cell damage), but the finding comes from a clinical population with cognitive impairment, so it's too early to assume the same benefit for healthy adults.
Big effectBifidobacterium for Reduced Malondialdehyde
Colostrum at 25 g/day pushed ventilatory threshold in endurance athletes — but didn't change their exhaustion time, body fat, or lactate
- 2025-04-20
- RCT
- European journal of sport science
This small crossover trial suggests bovine colostrum might shift a marker of aerobic efficiency, but the finding is preliminary and confined to trained males — and comes from a study where several other performance and body metrics flatlined, which puts the practical benefit in perspective.
SurprisingColostrum for Increased Time to Ventilatory Threshold
A meta-analysis linked NAC to a 9.7 percentage-point improvement in sperm motility — but the data come from clinical studies in infertile men, not the general population.
- 2025-03-24
- Meta-Analysis
- Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
This is the first strong evidence that NAC can improve semen quality in men with fertility issues, but it’s a single meta-analysis on a clinical population — so healthy men shouldn’t rush to supplement based on this alone.
New evidenceN-Acetyl Cysteine for Improved Total Sperm Motility
Adding saccharomyces boulardii to H. pylori therapy slashed diarrhea risk by 72% — but the benefit comes from a meta-analysis of a clinical population on antibiotics, not casual use.
- 2025-04-18
- Meta-Analysis
- BMC gastroenterology
This is a large, statistically robust effect in people already taking a harsh antibiotic cocktail, supported by 8 out of 10 studies showing benefit, but the evidence is only moderate overall and doesn't address whether the same reduction would occur in healthy people taking the yeast on its own.
Big effectsaccharomyces boulardii for Reduced Diarrhea Rate
After heart surgery, 19.5% of gastrodin patients developed delirium versus 35.9% on placebo — but the same study saw no difference in cognitive function.
- 2025-03-11
- RCT
- Critical care (London, England)
This single, early-stage trial suggests gastrodin might reduce a serious complication of cardiac surgery, but the lack of effect on cognitive dysfunction and the need for replication in larger studies means we should treat the result as promising but not definitive.
SurprisingGastrodia for Reduced Postoperative Delirium Incidence